Abstract
Objective: To compare stage at diagnosis of melanoma between non-Hispanic white, non-Hispanic black, and Hispanic patients. Design: Retrospective analysis. Setting: Melanoma cases reported to the Florida Cancer Data System, with known stage and race/ethnicity information, for residents of Miami-Dade County, Florida, from 1997 to 2002. Patients: Those diagnosed as having melanoma according to the Florida Cancer Data System. Main Outcome Measure: Stage of melanoma at diagnosis. Results: Of the 1690 melanoma cases reported with both stage and race/ethnicity information, 1176 (70%) were amongnon-Hispanic white patients, 485 (29%) were among Hispanic patients of any race, and 29 (2%) were among non-Hispanic black patients. Late-stage (regional and distant) diagnosis was more common among Hispanic (26%) and non-Hispanic black patients (52%) compared with non-Hispanic white patients (16%) (P<.001). Conclusion: Advanced stage of melanoma diagnosis among Hispanic and black patients suggests suboptimal secondary prevention efforts in minority populations.
| Original language | English |
|---|---|
| Pages (from-to) | 704-708 |
| Number of pages | 5 |
| Journal | Archives of Dermatology |
| Volume | 142 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 27 2006 |
Fingerprint
ASJC Scopus subject areas
- Dermatology
Cite this
Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida. / Hu, Shasa; Soza-Vento, Rita M.; Parker, Dorothy F.; Kirsner, Robert.
In: Archives of Dermatology, Vol. 142, No. 6, 27.06.2006, p. 704-708.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Comparison of stage at diagnosis of melanoma among Hispanic, black, and white patients in Miami-Dade County, Florida
AU - Hu, Shasa
AU - Soza-Vento, Rita M.
AU - Parker, Dorothy F.
AU - Kirsner, Robert
PY - 2006/6/27
Y1 - 2006/6/27
N2 - Objective: To compare stage at diagnosis of melanoma between non-Hispanic white, non-Hispanic black, and Hispanic patients. Design: Retrospective analysis. Setting: Melanoma cases reported to the Florida Cancer Data System, with known stage and race/ethnicity information, for residents of Miami-Dade County, Florida, from 1997 to 2002. Patients: Those diagnosed as having melanoma according to the Florida Cancer Data System. Main Outcome Measure: Stage of melanoma at diagnosis. Results: Of the 1690 melanoma cases reported with both stage and race/ethnicity information, 1176 (70%) were amongnon-Hispanic white patients, 485 (29%) were among Hispanic patients of any race, and 29 (2%) were among non-Hispanic black patients. Late-stage (regional and distant) diagnosis was more common among Hispanic (26%) and non-Hispanic black patients (52%) compared with non-Hispanic white patients (16%) (P<.001). Conclusion: Advanced stage of melanoma diagnosis among Hispanic and black patients suggests suboptimal secondary prevention efforts in minority populations.
AB - Objective: To compare stage at diagnosis of melanoma between non-Hispanic white, non-Hispanic black, and Hispanic patients. Design: Retrospective analysis. Setting: Melanoma cases reported to the Florida Cancer Data System, with known stage and race/ethnicity information, for residents of Miami-Dade County, Florida, from 1997 to 2002. Patients: Those diagnosed as having melanoma according to the Florida Cancer Data System. Main Outcome Measure: Stage of melanoma at diagnosis. Results: Of the 1690 melanoma cases reported with both stage and race/ethnicity information, 1176 (70%) were amongnon-Hispanic white patients, 485 (29%) were among Hispanic patients of any race, and 29 (2%) were among non-Hispanic black patients. Late-stage (regional and distant) diagnosis was more common among Hispanic (26%) and non-Hispanic black patients (52%) compared with non-Hispanic white patients (16%) (P<.001). Conclusion: Advanced stage of melanoma diagnosis among Hispanic and black patients suggests suboptimal secondary prevention efforts in minority populations.
UR - http://www.scopus.com/inward/record.url?scp=33745232051&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33745232051&partnerID=8YFLogxK
U2 - 10.1001/archderm.142.6.704
DO - 10.1001/archderm.142.6.704
M3 - Article
C2 - 16785372
AN - SCOPUS:33745232051
VL - 142
SP - 704
EP - 708
JO - JAMA Dermatology
JF - JAMA Dermatology
SN - 2168-6068
IS - 6
ER -